Related references
Note: Only part of the references are listed.2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Michael H. Le et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
Hong Sun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2022)
Renaming NAFLD to MAFLD: Advantages and Potential Changes in Diagnosis, Pathophysiology, Treatment, and Management
Fajuan Rui et al.
INFECTIOUS MICROBES & DISEASES (2022)
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
Alessandro Mantovani et al.
GUT (2021)
Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
Vy H. Nguyen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease
Ju Dong Yang et al.
HEPATOLOGY (2020)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
Helen Jarvis et al.
PLOS MEDICINE (2020)
Young-onset type 2 diabetes mellitus - implications for morbidity and mortality
Dianna J. Magliano et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis-implications for surveillance and future pharmacotherapy
Michael P. Johnston et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin et al.
LIVER INTERNATIONAL (2020)
Global trends in diabetes complications: a review of current evidence
Jessica L. Harding et al.
DIABETOLOGIA (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations
Marco Arrese et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Diabetes, cardiovascular disease and the microcirculation
W. David Strain et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997-2011
Lili Huo et al.
DIABETOLOGIA (2018)
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Amedeo Lonardo et al.
JOURNAL OF HEPATOLOGY (2018)
Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data
Edward W. Gregg et al.
LANCET (2018)
Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?
Matthew J. Armstrong et al.
HEPATOBILIARY SURGERY AND NUTRITION (2018)
Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK
Krishnan Bhaskaran et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies
Francesco Zaccardi et al.
DIABETOLOGIA (2017)
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
Leon A. Adams et al.
GUT (2017)
Comparison of Laboratory Tests, Ultrasound, or Magnetic Resonance Elastography to Detect Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Guangqin Xiao et al.
HEPATOLOGY (2017)
Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden
Russell Viner et al.
LANCET (2017)
The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment
Cristina Margini et al.
LIVER INTERNATIONAL (2016)
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Alexandra Kautzky-Willer et al.
ENDOCRINE REVIEWS (2016)
Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy
Gadi Shlomai et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Obesity and Cancer Mechanisms: Cancer Metabolism
Benjamin D. Hopkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants
Dagfinn Aune et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants
Dagfinn Aune et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Improved Survival Among Patients With Complicated Type 2 Diabetes in Denmark: A Prospective Study (2002-2010)
Kristine Faerch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Race/Ethnic Difference in Diabetes and Diabetic Complications
Elias K. Spanakis et al.
CURRENT DIABETES REPORTS (2013)
Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Maria Stepanova et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
Anna Ludovica Fracanzani et al.
HEPATOLOGY (2008)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Chronological development of elevated aminotransferases in a nonalcoholic population
A Suzuki et al.
HEPATOLOGY (2005)
Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world
F Levi et al.
HEART (2002)